Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD4<sup>+</sup> T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosis.

Science translational medicine·2026
Same author

Cryo-EM structure of the complex between transglutaminase 2 and the 45 kDa domain of fibronectin.

The Journal of biological chemistry·2026
Same author

A predisposing effect of HLA class II genes in celiac disease by skewing the naive CD4<sup>+</sup> T cell receptor repertoire.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Celiac disease plasma cells recognize the active form of transglutaminase 2 with and without bound substrate.

Journal of autoimmunity·2026
Same author

A model for predicting celiac disease among undiagnosed subjects established with data from the HUNT4 study.

BMC gastroenterology·2026
Same author

European Society for the Study of Coeliac Disease (ESsCD) 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 2: Management, Follow-Up, and Complex Disease Courses.

United European gastroenterology journal·2026

Related Experiment Video

Updated: Jun 24, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Antigen presentation in celiac disease.

Shuo-Wang Qiao1, Ludvig M Sollid, Richard S Blumberg

  • 1Centre for Immune Regulation, Institute of Immunology, Rikshospitalet University Hospital and University of Oslo, Norway. s.w.qiao@medisin.uio.no

Current Opinion in Immunology
|April 4, 2009
PubMed
Summary

Celiac disease stems from an immune reaction to gluten. Specific peptide fragments of gluten are key triggers, with HLA-DQ2 molecules uniquely binding these peptides, unlike HLA-DQ8.

More Related Videos

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

Basic Three-Dimensional (3D) Intestinal Model System with an Immune Component
07:39

Basic Three-Dimensional (3D) Intestinal Model System with an Immune Component

Published on: September 1, 2023

Related Experiment Videos

Last Updated: Jun 24, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

Basic Three-Dimensional (3D) Intestinal Model System with an Immune Component
07:39

Basic Three-Dimensional (3D) Intestinal Model System with an Immune Component

Published on: September 1, 2023

Area of Science:

  • Immunology
  • Gastroenterology
  • Molecular Biology

Background:

  • Celiac disease involves an abnormal immune response to gluten proteins found in wheat, barley, and rye.
  • Gluten digestion in the intestine produces peptide fragments that can trigger the disease.
  • Specific human leukocyte antigen (HLA) molecules play a critical role in presenting these peptides to the immune system.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying the immune response to gluten in celiac disease.
  • To understand the specific binding characteristics of HLA-DQ2 and HLA-DQ8 to gluten peptides.
  • To investigate why HLA-DQ2 is strongly associated with celiac disease susceptibility.

Main Methods:

  • Analysis of gluten peptide digestion products in the intestinal lumen.
  • Characterization of peptide binding to HLA-DQ2 and HLA-DQ8 molecules.
  • Comparison of binding affinities and structural interactions.

Main Results:

  • Gluten peptides undergo partial digestion, with deamidation being a crucial step for immune presentation.
  • The HLA-DQ2 molecule demonstrates a particular affinity for binding proline-rich gluten peptides.
  • HLA-DQ8 exhibits distinct binding characteristics compared to HLA-DQ2, correlating with a lower disease risk.

Conclusions:

  • The specific binding properties of HLA-DQ2 to deamidated gluten peptides are central to celiac disease pathogenesis.
  • Differences in HLA-DQ2 and HLA-DQ8 binding explain the varying genetic risks associated with these molecules.
  • Understanding these interactions provides insights into targeted therapies for celiac disease.